News Center

Viking Therapeutics shares surge on Pfizer’s drug discontinuation

Viking Therapeutics shares surge on Pfizer’s drug discontinuation

Investing.com -- Shares of Viking Therapeutics (NASDAQ:VKTX) rose sharply by 17% today, while Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) also saw gains of 1.7% and 4%, respectively. The upward movement in these pharmaceutical stocks comes after Pfizer Inc. (NYSE: NYSE:PFE) announced it would discontinue the development of its obesity drug candidate, danuglipron.Pfizer’s decision was base ...

2025-04-14 20:44:29
KKR signs $3.1 billion deal to buy OSTTRA from S&P Global and CME Group

KKR signs $3.1 billion deal to buy OSTTRA from S&P Global and CME Group

(Reuters) - U.S. private equity firm KKR will buy post-trade services company OSTTRA in a $3.1 billion deal, owners S&P Global and CME Group (NASDAQ:CME) announced on Monday.London-based OSTTRA, a joint venture between derivatives marketplace CME and financial data provider S&P Global, provides post-trade services for global over-the-counter markets across interest rate, foreign exchange, ...

2025-04-14 20:42:00
KeyBanc says smartphone tariff exception is ’best-case scenario’ for Apple

KeyBanc says smartphone tariff exception is ’best-case scenario’ for Apple

Investing.com -- Apple shares (NASDAQ:AAPL) jumped at the end of last week after the U.S. granted an exception for smartphones from the latest round of reciprocal tariffs, a move KeyBanc analysts described as “probably the best case scenario we can think of for AAPL.”The brokerage upgraded the stock to Sector Weight from Underweight, noting that the exemption “takes a big risk off the table. ...

2025-04-14 20:40:25
Barclays’s Cau upgrades quality European stocks, cuts value

Barclays’s Cau upgrades quality European stocks, cuts value

Investing.com -- Barclays strategists upgraded Quality European stocks to Positive while lowering Value to Neutral amid increasing recession risks.The move comes after global equity markets experienced declines in March and continued to face challenges into April, affected by tariff announcements and policy uncertainties.“The 90-day pause on higher reciprocal tariffs was a welcome reprieve, but ...

2025-04-14 20:35:35